View in EDS

Recombinant Bactericidal Permeability Increasing Protein (rBPI21) For Endotoxin (Lipopolysaccharide, LPS) Neutralization During Hematopoietic Stem Cell Transplantation (HSCT): Phase I/II Clinical Trial Results

Saved in:
Bibliographic Details
Title: Recombinant Bactericidal Permeability Increasing Protein (rBPI21) For Endotoxin (Lipopolysaccharide, LPS) Neutralization During Hematopoietic Stem Cell Transplantation (HSCT): Phase I/II Clinical Trial Results
Authors: Guinan, E.C.1,2, Avigan, D.E.3, Soiffer, R.J.1,4, Bunin, N.J.5, Russell, J.D.1, Stoler-Barak, L.2, Gallington, L.C.2, Walker, P.6, Scannon, P.J.7, Levy, O.2
Source: Biology of Blood & Marrow Transplantation. Feb2010 Supplement 2, Vol. 16 Issue 2, pS257-S257. 1p.
Database: Academic Search Ultimate
Description
ISSN:10838791
DOI:10.1016/j.bbmt.2009.12.311